Document Detail


Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.
MedLine Citation:
PMID:  9181267     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
HYPOTHESIS: This study was undertaken to determine whether echo-derived left atrial dimension and other echocardiographic, clinical, and hemodynamic parameters detected at the time of entry into the study may influence prognosis in patients with dilated cardiomyopathy during a long-term follow-up. METHODS: This was a prospective cohort analysis of 123 patients with dilated cardiomyopathy. Clinical evaluation, chest x-ray, M-mode and two-dimensional echocardiogram, exercise test, 72-h ambulatory electrocardiogram monitoring, and cardiac catheterization study were performed in all patients. The study was divided into two phases: in the first phase, patients were divided into two groups according to the left atrial size (> or = 45 mm; < 45 mm), with cardiac death as the end point. In the second phase, all patients were further divided into two groups according to their clinical course. A multivariate analysis was performed to determine independent correlated parameters of cardiac mortality and overall clinical outcome. RESULTS: Cardiac mortality rate was 47.9%: 29% in the group without left atrial dilation and 54.3% in the group with dilated left atrium. Multivariate analysis revealed that left atrium > or = 45 mm, New York Heart Association functional classes III/IV, and the presence of one or more episodes of ventricular tachycardia at Holter monitoring were independent predictors of cardiac mortality, while left atrium > or = 45 mm, left ventricular end-diastolic pressure > 17 mmHg, and exercise tolerance < or = 15 min were independent predictors of poor clinical outcome. CONCLUSIONS: Our results revealed that left atrial size is the principal independent predictor of prognosis in patients with dilated cardiomyopathy in that patients with left atrial dilation had an increase in mortality and a worse clinical outcome compared with those without left atrial dilation.
Authors:
M G Modena; N Muia; F A Sgura; R Molinari; A Castella; R Rossi
Related Documents :
14571497 - Transcatheter left atrial appendage occlusion with amplatzer devices to obviate anticoa...
22329787 - Simultaneous hypertrophic cardiomyopathy and muscular ventricular septal defect in an a...
2578647 - Acute and long-term atrial and ventricular stimulation thresholds with a steroid-elutin...
22833857 - Assessment of cardiac abnormalities in duchenne's muscular dystrophy by (99m)tc-mibi ga...
1751957 - Anomalous coronary arteries: a report of 2 cases of single coronary artery.
910727 - Provocative testing for coronary arterial spasm: rationale, risk and clinical illustrat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical cardiology     Volume:  20     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-07-31     Completed Date:  1997-07-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  553-60     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Modena, Modena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cardiomyopathy, Dilated / mortality*,  pathology
Case-Control Studies
Discriminant Analysis
Echocardiography
Female
Follow-Up Studies
Heart Atria / pathology*
Hemodynamics
Humans
Italy / epidemiology
Life Tables
Male
Middle Aged
Prognosis
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Routine arterial oxygen saturation monitoring is not necessary during transesophageal echocardiograp...
Next Document:  Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.